EN DE
Watch Bath & Body Works Inc. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Bath & Body Works Inc. (BBWI) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Bath & Body Works Inc. stock $47.08, price $21.36, upside +120.4%, quality 70 out of 100. Rating: strongly undervalued. Calculated from audited financials with 21 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Cyclical US

BB Bath & Body Works Inc. logo Some data Nov 7, 2026

Bath & Body Works Inc.

BBWI · US
Undervalued, but in a downtrend

The stock costs 55% less than our calculation considers fair.

Fair value $47.08 · Strongly undervalued (55%)
Quality 70/100
Solidly profitable · 10.8% net margin (TTM)
Generates free cash flow
3.7% dividend yield · Well covered
Ranks above peers (11/12)
Positive coverage
Costs just 5.6 times its yearly profit.
Mixed Growth (revenue 5y +2.5 %/yr in USD)
Negative equity (buybacks among others)
Moderate moat 53/100 · thin data
Insiders sold $14 (6M)
Some data

Risks from the AI analysis

🚩Amazon and DTC rivals capture share🚩Concentrated supplier base in Beauty Park
Watch Bath & Body Works Inc. for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$69.18 $14.41 Fair Value $47.08 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.

How to read this chart

60‑month range $14.41 – $69.18 · fair‑value band $32.69 – $69.41 · the $21.36 price screens below the $47.08 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.

Follow Bath & Body Works in your weekly email

Every Wednesday you see whether Bath & Body Works is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products.

Show moreShow less

The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products.

It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the franchise, license, and wholesale arrangements.

The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.

Stock analysis

Bath & Body Works Inc. (BBWI) currently trades at $21.36, while our model-based Fair Value estimate is $47.08, implying the stock looks roughly 55% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $62.28 per share, and 19 of the 21 models we run sit above the $21.36 price.

Bear case: the Dividend Discount group reads lowest at $8.01, and 2 of the 21 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $32.69 (bear) to $69.41 (bull), the price of $21.36 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 70/100 (solid quality), in the Consumer Cyclical sector.

Mixed Growth: Spin-off in 2021: revenue and profit before it include the divested business. Growth is measured afresh from 2021.

Bath & Body Works Inc. reported revenue of $7.3B in FY2026 versus $7.9B in FY2022, a compound −1.9%/yr. Reported net income was $649M in FY2026, compounding −16.5%/yr from FY2022.

Key figures

Market cap $4.5B Mid · P/E ratio 5.6 · P/S ratio 0.63 · EPS (TTM) $3.80 · Dividend yield 3.7% · Net margin 10.8% · Return on assets (EBIT) 26.0% (5-year average) · Operating margin 9.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 53 out of 100 (low confidence).

What moves the price

The share trades about 11% below its 52-week high and 48% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Cyclical peers we cover trades at −5% fair-value upside, at 120%, BBWI screens cheaper than that median.

Fair Value models

Bear $32.69 Fair Value $47.08 Bull $69.41
Price $21.36 · Upside +120.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 9 months old). Earnings retained since then ($2.31 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $32.84 $45.58 $69.41 80
Growth DCF $34.17 $46.41 $67.32 79
Owner Earnings $29.19 $40.92 $62.86 76
All 21 models by family
DCF Models
FCF DCF $32.84 $45.58 $69.41 80
Owner Earnings $29.19 $40.92 $62.86 76
5Y Revenue Exit $22.47 $34.82 $53.47 72
5Y EBITDA Exit $36.91 $59.31 $90.04 74
5Y P/E Exit $32.69 $52.16 $76.31 70
10Y Revenue Exit $25.89 $36.56 $48.21 67
10Y EBITDA Exit $34.80 $51.41 $69.88 69
10Y P/E Exit $32.40 $47.08 $61.74 64
Earnings-Based
Graham-Dodd $21.89 $34.93 $42.06 67
EPV $23.10 $28.19 $32.45 74
Dividend Discount
Gordon GGM $6.58 $7.69 $8.85 69
DDM Multi-Stage $6.58 $8.33 $10.31 67
Multiples
P/E Multiple $53.11 $70.81 $88.51 63
P/S Multiple $32.54 $43.39 $54.24 58
EV/EBIT $55.54 $80.67 $105.80 65
EV/EBITDA $41.75 $62.28 $82.81 66
EV/Revenue $10.53 $23.55 $36.56 51
Growth DCF
Growth DCF $34.17 $46.41 $67.32 79
Rev-Margin DCF $22.47 $35.98 $53.51 72
Economic Profit
ROIC Compounder $23.36 $28.89 $34.07 72
Growth Earnings
Growth-Adj P/E $37.44 $53.48 $69.52 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 70/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 80
How much profit the company makes from its sales and capital
Quality Growth 23
Are margins and returns getting better?
Cashflow 67
Do the profits arrive as real cash?
Financial strength 50
Debt, balance sheet and risk of trouble
Investment 97
Does it invest with discipline instead of growing at any price?
Low Volatility 15
How calm the share price moves, does not count
Price momentum 40
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 50
Distance to the 52-week high, does not count
New shares 100
Buys back shares or issues new ones?

Open the full quality analysis →

Insider trades

In the last 6 months, one officer or director sold shares worth $14 and none bought.

  • SaleSarah E NashDirector0.69 shares at $20.56$14Oct 16, 2026
  • BuySarah E NashDirector10,000 shares at $15.58$155,800Nov 24, 2025
  • BuyJames Kevin SymancykDirector22,500 shares at $15.58$350,550Nov 24, 2025
  • BuyLucy BradyDirector3,470 shares at $14.40$49,962Nov 21, 2025
  • BuyFrancis HondalDirector3,343 shares at $15.00$50,145Nov 21, 2025
  • BuyStephen D SteinourDirector6,700 shares at $14.86$99,562Nov 21, 2025
  • BuySteven E VoskuilDirector20,000 shares at $15.04$300,800Nov 21, 2025

Plus 13 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.

Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.

Source: SEC Form 4, as of Nov 6, 2026. All filings at the SEC ↗

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 55/100
Spin-off in 2021: revenue and profit before it include the divested business. Growth is measured afresh from 2021.
Revenue growth 1 year
−0.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.5%
Start year 2021 (pandemic)
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
+4.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+0.4%
Dividend (yield on the price)3.7%
Per share before 2021divided by the spin-off factor 1.237
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−4.9% vs −0.5%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.25% → 15%
Pace: the 5-year rate starts in 2021 (pandemic)

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−3.7%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+0.8%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −5.9% a year for the price and −1.5% for the forecasts.
Forecast 2027 (sales)−2.6%
Forecast 2028 (sales)+1.7%
Projected 2029 (sales)+1.7%
Projected 2030 (sales)+1.7%
Projected 2031 (sales)+1.8%

Watch BBWI, get fair value alerts →

Recent news

News mood ⓘNews mood, the average tone of recent news (99 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation. Positive
Recent news coverage is more positive than average.
Note from the team Oct 31, 2026
AI conclusion: International network growth lifts overseas sales while negative equity and high debt constrain overall business durability.
Main risk: Direct-to-consumer brands and smaller competitors on Amazon and TikTok Shop could draw customers away from Bath & Body Works stores and website, pressuring sales volumes and margins in core personal care categories.
Bull case: By using its AI-powered tools and expanded presence on Amazon and Ulta to attract new customers while strengthening core fragrance offerings, Bath & Body Works could gain incremental sales and improve efficiency across channels.
Bear case: If platform rivals and direct-to-consumer brands draw customers away and the concentrated supplier network faces disruptions, Bath & Body Works could encounter pressure on sales and higher costs that hinder its transformation.
Bath & Body Works has expanded its international network to 596 stores, with overseas sales rising in the high single digits and net sales up low double digits in the latest quarter. This adds support to the multiyear transformation that the CEO calls an investment year for 2026. Will the overseas momentum outweigh the costs of reshaping domestic stores and exiting categories enough to deliver sustainable growth?
Join the discussion →

Compare Bath & Body Works Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Retail · 203 stocks

Beats the industry median on 11/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 70 · Top 25%
Fair Value upside +120.4% · Top 25%
Profitability
Return on equity (12 months) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets 12.8% · Top 25%
Net margin (12 months) 10.8% · Top 25%
Operating margin (12 months) 9.6% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) −2.3% · Bottom 25%
Dividend yield (12 months) 3.7% · Above median
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Specialty Retail median · lower = cheaper

P/E (12 months) 5.6× · Cheapest 25%
P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months) 0.63× · Cheaper than median
Price / free cash flow (fiscal year) 5.2× · Cheapest 25%
EV/EBITDA 5.5× · Cheaper than median
PEG 0.70× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 51
FUTURE (revenue growth)0 · sector 25
PAST (return on equity)0 · sector 33
HEALTH (low debt)0 · sector 93
DIVIDEND (yield)75 · sector 54

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Retail stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
DICK'S Sporting Goods, Inc DKS $140.82 $201.62 +43% vs BBWI
Alimentation Couche-Tard Inc ATD C$83.20 C$106.00 +27% vs BBWI
Ulta Beauty, Inc ULTA $644.76 $650.56 +1% vs BBWI
Tractor Supply Company TSCO $36.35 $36.33 +0% vs BBWI
Best Buy Co BBY $99.63 $94.70 −5% vs BBWI
China Tourism Group 601888 ¥54.22 ¥48.19 −11% vs BBWI
Five Below, Inc FIVE $240.30 $184.99 −23% vs BBWI
Williams-Sonoma, Inc WSM $254.06 $164.11 −35% vs BBWI
Casey's General Stores, Inc CASY $687.64 $405.93 −41% vs BBWI
GameStop Corp GME $25.12 $11.87 −53% vs BBWI

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Bath & Body Works Inc.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Bath & Body Works Inc. Fair Value". https://www.fairvalue-calculator.com/stock/BBWI

Frequently asked questions

Is Bath & Body Works Inc. (BBWI) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of $47.08 versus a price of $21.36, about +120% upside (undervalued).
What is the fair value of BBWI?
Our model-based fair value for Bath & Body Works Inc. is $47.08 (as of Nov 7, 2026), built from audited fundamentals. The current price: $21.36.
What is the quality score of BBWI?
Bath & Body Works Inc. has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bath & Body Works Inc. (BBWI)?
Our model-based price target is the fair value of $47.08 (as of Nov 7, 2026) from 21 valuation models. Cautious scenario $32.69, optimistic scenario $69.41. It is a calculation from audited fundamentals, not an analyst target.
What is the Bath & Body Works Inc. stock forecast for 2026?
Our models put fair value at $47.08, about +120% upside versus a price of $21.36 (undervalued). Cautious scenario $32.69, optimistic scenario $69.41. The calculation is refreshed regularly with new filings.
What is the revenue of Bath & Body Works Inc. (BBWI)?
Bath & Body Works Inc. reported trailing-twelve-month revenue of about $7.2B (latest available figure, as of Nov 7, 2026).
Does Bath & Body Works Inc. pay a dividend?
Bath & Body Works Inc. currently shows a dividend yield of 3.75% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Bath & Body Works Inc. (BBWI) and when is the ex-dividend date?
Bath & Body Works Inc. pays a dividend of $0.8 per share a year, a dividend yield of 3.7%. The last ex-dividend date was Aug 21, 2026. A dividend has been paid every year since at least 1985. The payout ratio is 21.1% of earnings. Free cash flow covers the dividend 5.36 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Bath & Body Works Inc. (BBWI)?
For today's price to be fair in a discounted-cash-flow model, Bath & Body Works Inc. would have to grow free cash flow by -3.7 % per year for five years (discount rate 10.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.5 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of BBWI use?
Our models discount Bath & Body Works Inc. at 10.7 %: a base by market capitalisation (mid), damped by beta 1.40, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Bath & Body Works Inc. that is -3.7 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.7 %) and the same formula as our fair value.
How much growth has Bath & Body Works Inc. (BBWI) delivered so far?
Over the past 5 years revenue at Bath & Body Works Inc. grew +2.5 % a year. The price currently implies free-cash-flow growth of -3.7 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Bath & Body Works Inc. (BBWI) growing?
The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Bath & Body Works Inc. (-3.7 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Bath & Body Works Inc. (BBWI)?
The free-cash-flow yield on the price is 19.14 %: that much free cash flow Bath & Body Works Inc. produces per unit of market value. When it exceeds the discount rate of our models (10.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Bath & Body Works Inc. (BBWI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bath & Body Works Inc. it is $47.08 per share (as of Nov 7, 2026), against a price of $21.36. It is the blended result of 21 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Growth DCF, Economic Profit, Growth Earnings).
Is Bath & Body Works Inc. stock overvalued or undervalued in 2026?
As of Nov 7, 2026, BBWI trades below its calculated fair value: price $21.36, fair value $47.08, a gap of about +120% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BBWI?
No. The price is what the market pays today ($21.36); the fair value is what the company's own numbers justify ($47.08). For Bath & Body Works Inc. the two are $25.72 per share apart. That gap is exactly why we show both numbers side by side.
How much is Bath & Body Works Inc. worth?
The market values Bath & Body Works Inc. at about $4.5B (market capitalisation, as of Nov 7, 2026). Per share that is $21.36; our models calculate a fair value of $47.08 per share.
What do the bullish and bearish scenarios say about BBWI?
Our models span a range for Bath & Body Works Inc.: cautious scenario $32.69, base $47.08, optimistic $69.41 per share (as of Nov 7, 2026, price $21.36). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BBWI?
Bath & Body Works Inc. trades at a price-to-earnings ratio of 5.6 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $47.08 is built from several models across several years. Median P/E at fiscal year-end, 5 fiscal years (2022 to 2026), reported earnings, FY2022, FY2026 ex one-offs: 11.1. Other multiples: PEG 0.7, P/S 0.6, EV/EBITDA 5.5.
What is the PEG ratio of BBWI?
The PEG ratio of Bath & Body Works Inc. is 0.70 (P/E divided by earnings growth, as of Nov 7, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Bath & Body Works Inc. (BBWI)?
Balance-sheet figures for Bath & Body Works Inc. (as of Nov 7, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
How far is BBWI from its 52-week high?
Bath & Body Works Inc. trades at $21.36, about 11% below its 52-week high of $23.95 and 48% above the low of $14.41 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $47.08 is for.
Which stocks are comparable to Bath & Body Works Inc.?
From the same area (Consumer Cyclical) we also value Alimentation Couche-Tard Inc, Williams-Sonoma, Inc, Ulta Beauty, Inc, Casey's General Stores, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bath & Body Works Inc. stock attractive at the current price?
The data as of Nov 7, 2026: price $21.36, calculated fair value $47.08 (+120%), Quality Score 70/100, from 21 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BBWI calculated?
We run Bath & Body Works Inc. through 21 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of $47.08 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Bath & Body Works Inc. currently trades 55% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Bath & Body Works Inc. (BBWI)?
The closing price on Nov 6, 2026 was $21.36. Our model-based fair value is $47.08, about +120% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Bath & Body Works Inc. right now?
The price is below even our cautious bear case ($32.69). The market is more pessimistic than our downside scenario. Solid quality (70/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range ($32.69 to $69.41) leaves room in how you read the outcome.
Where does the earnings growth of Bath & Body Works Inc. (BBWI) come from?
Earnings per share at Bath & Body Works Inc. grew −1.1 % a year from 2015 to 2026. Broken into its drivers: revenue per share −2.2 %, EBIT margin −0.2 %, tax rate +2.1 %, residual (interest, one-offs) −0.8 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Bath & Body Works Inc.

How large is the market capitalisation of Bath & Body Works Inc. (BBWI)?
The market capitalisation of Bath & Body Works Inc. is $4.5B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Bath & Body Works Inc. (BBWI)?
The price-to-sales ratio of Bath & Body Works Inc. is 0.63 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Bath & Body Works Inc. (BBWI)?
Earnings per share at Bath & Body Works Inc. are $3.80 (price ÷ EPS = P/E 5.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Bath & Body Works Inc. (BBWI)?
The dividend yield of Bath & Body Works Inc. is 3.7% (payout 21.1%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Bath & Body Works Inc. (BBWI)?
The net margin of Bath & Body Works Inc. is 10.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Bath & Body Works Inc. (BBWI)?
On an EBIT basis the return on assets of Bath & Body Works Inc. is 26.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Bath & Body Works Inc. (BBWI)?
The operating margin of Bath & Body Works Inc. is 9.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Bath & Body Works Inc. (BBWI)?
Revenue at Bath & Body Works Inc. is growing −2.3% versus a year earlier (3y avg −1.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Bath & Body Works Inc. (BBWI)?
Earnings per share at Bath & Body Works Inc. are growing +93.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Bath & Body Works Inc. (BBWI) carry?
The net debt of Bath & Body Works Inc. is $4.0B (fiscal year 2026, ≈ 4.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Bath & Body Works Inc. in the live analysis

One click puts Bath & Body Works Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.